Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management
Provides tools and enablers to facilitate post-approval chemistry, manufacturing, and controls (CMC) changes. Introduces Established Conditions (ECs), Product Lifecycle Management Document (PLCM), and Post-Approval Change Management Protocols (PACMPs).
Post-approval lifecycle management for all pharmaceutical products. Enables more efficient regulatory management of changes to approved products.
- 01Established Conditions (ECs) must be defined at approval — these trigger reporting obligations when changed
- 02Product Lifecycle Management Document (PLCM) — optional but simplifies lifecycle management
- 03Post-Approval Change Management Protocols (PACMPs) pre-define the conditions for specific changes
- 04Structured approach to change categorisation: major vs minor reporting
November 2019. Implementation guidance published 2021. FDA implementing regulations still in development.
ICH Q12: frequently asked questions
Quick answers to common questions about ICH Q12.
What is ICH Q12?
ICH Q12 — Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management — is a guidance issued by the International Council for Harmonisation. Provides tools and enablers to facilitate post-approval chemistry, manufacturing, and controls (CMC) changes. Introduces Established Conditions (ECs), Product Lifecycle Management Document (PLCM), and Post-Approval Change Management Protocols (PACMPs).
Who does ICH Q12 apply to?
Post-approval lifecycle management for all pharmaceutical products. Enables more efficient regulatory management of changes to approved products.
What are the key requirements of ICH Q12?
ICH Q12 requires, among other things: Established Conditions (ECs) must be defined at approval — these trigger reporting obligations when changed; Product Lifecycle Management Document (PLCM) — optional but simplifies lifecycle management; Post-Approval Change Management Protocols (PACMPs) pre-define the conditions for specific changes; Structured approach to change categorisation: major vs minor reporting.
When was ICH Q12 last updated?
The current version of ICH Q12 dates from November 2019. November 2019. Implementation guidance published 2021. FDA implementing regulations still in development.
Live openFDA recalls SPEQ maps to this standard’s topics — a SPEQ interpretation, not an FDA classification.
Recall domain is a SPEQ mapping of this standard’s topics, not an FDA classification.
Track the standards that move
When ICH Q12 — or any GxP requirement — is revised, recalled against, or clarified by new guidance, the Weekly GxP Briefing surfaces it. Free, one email a week.